Cancer Management during COVID-19 Pandemic: Is Immune Checkpoint Inhibitors-Based Immunotherapy Harmful or Beneficial?

The coronavirus disease 2019 (COVID-19) is currently representing a global health threat especially for fragile individuals, such as cancer patients. It was demonstrated that cancer patients have an increased risk of developing a worse symptomatology upon severe acute respiratory syndrome associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Vivarelli, Silvia, Falzone, Luca, Grillo, Caterina Maria, Scandurra, Giuseppa, Torino, Francesco, Libra, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465907/
https://www.ncbi.nlm.nih.gov/pubmed/32785162
http://dx.doi.org/10.3390/cancers12082237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465907/
https://www.ncbi.nlm.nih.gov/pubmed/32785162
http://dx.doi.org/10.3390/cancers12082237

Ejemplares similares